The Food and Drug Administration approved Eli Lilly’s weight-loss drug Zepbound on Dec. 27 to treat sleep apnea, a common but ...

A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. Experts ...

The Food and Drug Administration (FDA) announced the approval of the weight loss drug Zepbound, generically known as ...

The first medication for obstructive sleep apnea has been approved by the US Food and Drug Administration (FDA).

The U.S. Food and Drug Administration on Friday approved the first prescription medicine for obstructive sleep apnea: the ...

The Food and Drug Administration (FDA) approved a weight-loss drug to help sleep apnea, becoming the first drug to treat the ...

Zepbound, Eli Lilly’s weight loss drug, can now be used to treat obstructive sleep apnea in adults with obesity, the FDA said ...

The FDA first approved Zepbound to treat obesity in November ... to treat Type 2 diabetes and became popular as an off-label weight-loss treatment. Tirzepatide works by stimulating two hormones ...

called the FDA’s approval a "promising advancement for the millions of people who suffer from this condition." "Zepbound promotes weight loss and has been shown to reduce apnea events." ...

which was approved for weight loss for those with obesity, or who are overweight and have a weight-related health condition, in November 2023.Although the new FDA green light doesn't expand the ...